RESPORAL Drug Patent Profile
✉ Email this page to a colleague
When do Resporal patents expire, and what generic alternatives are available?
Resporal is a drug marketed by Pioneer Pharms and is included in one NDA.
The generic ingredient in RESPORAL is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RESPORAL?
- What are the global sales for RESPORAL?
- What is Average Wholesale Price for RESPORAL?
Summary for RESPORAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | RESPORAL at DailyMed |
US Patents and Regulatory Information for RESPORAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pioneer Pharms | RESPORAL | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 089139-001 | Jun 16, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
